{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:23:07Z","timestamp":1779315787234,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1124\/jpet.112.199752","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T04:43:36Z","timestamp":1363841016000},"page":"404-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Parathyroid Hormone (PTH) and PTH-Related Peptide Domains Contributing to Activation of Different PTH Receptor\u2013Mediated Signaling Pathways"],"prefix":"10.1016","volume":"345","author":[{"given":"Meghan E.","family":"Cupp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra K.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina S.","family":"Adem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.199752_bib1","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199752_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-61779-909-9_9","article-title":"Measurements of \u03b2-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation","volume":"897","author":"Bassoni","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1124\/jpet.112.199752_bib3","doi-asserted-by":"crossref","first-page":"38524","DOI":"10.1074\/jbc.M202544200","article-title":"Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations","volume":"277","author":"Bisello","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.040","article-title":"Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids","volume":"611","author":"Caporale","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199752_bib5","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00726-010-0591-6","article-title":"Synthesis and structural studies of new analogues of PTH(1-11) containing C\u03b1-tetra-substituted amino acids in position 8","volume":"39","author":"Caporale","year":"2010","journal-title":"Amino Acids"},{"key":"10.1124\/jpet.112.199752_bib6","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1073\/pnas.0503942102","article-title":"Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism","volume":"102","author":"Castro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199752_bib7","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.112.199752_bib8","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2004-1282","article-title":"Bone response to intermittent parathyroid hormone is altered in mice null for beta-Arrestin2","volume":"146","author":"Ferrari","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199752_bib9","unstructured":"Fitzpatrick LA, Bilezikian JP (1996) Principles of Bone Biology (Bilezikian JP, Raisz LG, Rodan GA, eds, ed) pp 339\u2013346, Academic Press, Inc., San Diego, CA."},{"key":"10.1124\/jpet.112.199752_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1043-2760(01)00409-X","article-title":"Molecular properties of the PTH\/PTHrP receptor","volume":"12","author":"Gardella","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/jpet.112.199752_bib11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","article-title":"Parathyroid hormone and parathyroid hormone-related peptide, and their receptors","volume":"328","author":"Gensure","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.112.199752_bib12","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","article-title":"Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation","volume":"281","author":"Gesty-Palmer","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3000071","article-title":"A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation","volume":"1","author":"Gesty-Palmer","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1124\/jpet.112.199752_bib14","doi-asserted-by":"crossref","unstructured":"Guo J, Liu M, Yang D, Bouxsein ML, Thomas CC, Schipani E, Bringhurst FR, Kronenberg HM (2010) Phospholipase C signaling via the parathyroid hormone (PTH)\/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 15. Endocrinology 151:3502\u20133513.","DOI":"10.1210\/en.2009-1494"},{"key":"10.1124\/jpet.112.199752_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S8756-3282(96)00230-X","article-title":"Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo","volume":"19","author":"Hilliker","year":"1996","journal-title":"Bone"},{"key":"10.1124\/jpet.112.199752_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jbmr.5650070110","article-title":"Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone","volume":"7","author":"Hock","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.112.199752_bib17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"10.1124\/jpet.112.199752_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3299","article-title":"Emerging therapeutic opportunities for skeletal restoration","volume":"10","author":"Kawai","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.112.199752_bib21","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/mol.107.040352","article-title":"Functional selectivity through protean and biased agonism: who steers the ship?","volume":"72","author":"Kenakin","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.199752_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199752_bib22","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199752_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1087057108327329","article-title":"Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay","volume":"14","author":"McGuinness","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.112.199752_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bone.2004.08.015","article-title":"In vitro and in vivo activities of C-terminally truncated PTH peptides reveal a disconnect between cAMP signaling and functional activity","volume":"35","author":"Murrills","year":"2004","journal-title":"Bone"},{"key":"10.1124\/jpet.112.199752_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bone.2011.02.019","article-title":"ZP2307, a novel, cyclic PTH(1-17) analog that augments bone mass in ovariectomized rats","volume":"48","author":"Neerup","year":"2011","journal-title":"Bone"},{"key":"10.1124\/jpet.112.199752_bib26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1087057111406548","article-title":"Understanding the effect of different assay formats on agonist parameters: a study using the \u00b5-opioid receptor","volume":"16","author":"Nickolls","year":"2011","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.112.199752_bib51","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1074\/jbc.M110.200196","article-title":"G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone","volume":"286","author":"Ogata","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib27","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1073\/pnas.0808750105","article-title":"Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation","volume":"105","author":"Okazaki","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199752_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/adt.2006.052","article-title":"Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery","volume":"5","author":"Olson","year":"2007","journal-title":"Assay Drug Dev Technol"},{"key":"10.1124\/jpet.112.199752_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1359\/jbmr.081237","article-title":"Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice","volume":"24","author":"Pierroz","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.112.199752_bib30","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.0801027105","article-title":"Molecular recognition of parathyroid hormone by its G protein-coupled receptor","volume":"105","author":"Pioszak","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199752_bib31","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides","volume":"284","author":"Pioszak","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","article-title":"Quantifying ligand bias at seven-transmembrane receptors","volume":"80","author":"Rajagopal","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.199752_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","article-title":"Molecular mechanism of \u03b2-arrestin-biased agonism at seven-transmembrane receptors","volume":"52","author":"Reiter","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.112.199752_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3349\/ymj.2006.47.2.214","article-title":"In vitro and in vivo effect of parathyroid hormone analogue (1-14) containing -amino-iso-butyric acid residue (Aib)1,3","volume":"47","author":"Rhee","year":"2006","journal-title":"Yonsei Med J"},{"key":"10.1124\/jpet.112.199752_bib35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jbmr.5650090807","article-title":"Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase","volume":"9","author":"Rixon","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.112.199752_bib36","doi-asserted-by":"crossref","first-page":"49003","DOI":"10.1074\/jbc.M106827200","article-title":"Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor","volume":"276","author":"Shimizu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib37","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1359\/jbmr.040914","article-title":"Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3","volume":"19","author":"Shimizu","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.112.199752_bib38","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1210\/en.2003-1185","article-title":"Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments","volume":"145","author":"Sneddon","year":"2004","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199752_bib39","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M413393200","article-title":"Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling","volume":"280","author":"Syme","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199752_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.1999.14.1.11","article-title":"Dual signaling and ligand selectivity of the human PTH\/PTHrP receptor","volume":"14","author":"Takasu","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.112.199752_bib41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/endo-110-2-506","article-title":"Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration","volume":"110","author":"Tam","year":"1982","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199752_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/BST20110615","article-title":"From parathyroid hormone to cytosolic Ca2+ signals","volume":"40","author":"Taylor","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/jpet.112.199752_bib43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1517\/17460441.2011.608658","article-title":"Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay","volume":"6","author":"Trinquet","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.112.199752_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199752_bib45","doi-asserted-by":"crossref","unstructured":"van der Lee MM, Verkaar F, Wat JW, van Offenbeek J, Timmerman M, Voorneveld L, van Lith LH, and Zaman GJ (2013) \u03b2-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor. Cell Signal 25:527\u2013538.","DOI":"10.1016\/j.cellsig.2012.11.012"},{"key":"10.1124\/jpet.112.199752_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.112.199752_bib47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jcb.22883","article-title":"Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active G\u03b1(12) or constitutively active RhoA","volume":"111","author":"Wang","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1124\/jpet.112.199752_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02529728","article-title":"Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin)","volume":"58","author":"Whitfield","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1124\/jpet.112.199752_bib49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","article-title":"Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone","volume":"40","author":"Yang","year":"2007","journal-title":"Bone"},{"key":"10.1124\/jpet.112.199752_bib50","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.1074\/jbc.M806516200","article-title":"Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay","volume":"284","author":"Yin","year":"2009","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.199752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:22:06Z","timestamp":1739985726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0022356524186090"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.199752","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid Hormone (PTH) and PTH-Related Peptide Domains Contributing to Activation of Different PTH Receptor\u2013Mediated Signaling Pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.199752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}